EdgeWater 10/20/2010 12:00:03 PM
News / Business

Drug Stocks in Spotlight (JNJ, KG, PFE, UNH)

Drug Stocks

Johnson & Johnson (NYSE:JNJ) slid 0.89% to $63.29. The company reported a higher third-quarter profit, although sales came in slightly below those of the same quarter in 2009. J&J said it earned $3.42 billion, or $1.23 a share, compared with $3.35 billion, $1.20 a share, for the prior year's quarter.

A poll of analysts by FactSet Research estimated that J&J would post earnings of $1.15 a share, on revenue of $15.24 billion.

Over the past 52-week, the stock had traded within the range of $56.86-$66.20.  

King Pharmaceuticals, Inc. (NYSE:KG) went down 0.14% to $14.16 after the stock made its fresh 52-week high of $14.18.

Over the past five trading sessions, the stock went up more than 37%. At today`s closing market price, the market capitalization of the company stands at $3.54 billion.

Pfizer Inc. (NYSE:PFE) fell 2.30% to $17.39 on unusual volumes. Dow Jones reported that Pfizer is in advanced talks to acquire control of Brazilian generic drugs manufacturer Teuto, local newspaper O Estado de S. Paulo reported. The company may announce the deal in the next few days.

 Over the past 52-week, the stock traded within the range of $14-$20.36.

UnitedHealth Group Inc. (NYSE:UNH) lost 2.62% to $35.30. The company reported third-quarter net income rose 23% on 9.1% higher revenue. Earnings reached $1.28 billion, or $1.14 a share, from $1.04 billion, or 89 cents, in the year-earlier period.

A survey of analysts by FactSet produced consensus estimates of 83 cents of profit on $23.27 billion of revenue.

At today`s closing market price, the market capitalization of the company stands at $39.69 billion.


Article published by Wall Street Grand. Visit the Wall Street Grand Club today.

SAFE LINK

Disclaimer:

For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html